PRPO logo

PRECIPIO INC

PRPONASDAQ
πŸ† #4372 by market capEarnings Apr 5US Equity
$17.35β–Ό $1.14 (βˆ’6.17%)
Market closed Β· at close
πŸ””
Track PRPO
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 6.2%
7dβ–Ό 23.2%
14dβ–Ό 9.2%
30dβ–Ό 16.4%
ytdβ–Ό 25.2%
1yβ–Ό 24.2%
🏦Market Cap
$31M
Small Cap
πŸ“ˆRevenue Growth (YoY)
28.0%
High Growth
πŸ“ŠGross Margin
44.1%
Healthy
πŸ’΅FCF Margin
3.1%
Moderate
βš–οΈP/S Ratio
1.1x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$17.30 – $19.73
52-Week Range
$17.30 – $33.63
Volume (shares)
35,650
Avg Volume (shares)
β€”
Shares Outstanding
1.8M
Next Earnings
2027-04-05

Fundamentals Snapshot

Annual Revenue
$24M
Last Q Revenue
$7M
P/E Ratio
β€”
P/S Ratio
1.1x
EPS (TTM)
$-0.68
Dividend Yield
β€”
Dilution (1yr)
+7.5%
PRPO logo

PRECIPIO INC

PRPO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$24Mβ–² +50.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
44.5%β–Ό βˆ’6.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$1Mβ–Ό βˆ’71.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$359Kβ–² +66.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.6Mβ–² +7.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$2Mβ–² +$2M YoY
StockOtter Β· stockotter.space

About PRECIPIO INC

Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

Zacks Investment ResearchΒ·6d ago

PRPO Stock Slips Post Q3 Earnings Despite Revenue and Product Growth

Precipio's third-quarter 2026 results show solid product revenue growth, improved profitability and bold expansion plans despite lingering liquidity concerns.

Seeking AlphaΒ·11d ago

Precipio, Inc. (PRPO) Q3 2026 Earnings Call Transcript

Precipio, Inc. (PRPO) Q3 2026 Earnings Call Transcript

GlobeNewsWireΒ·12d ago

Precipio Announces Q3-2026 Financial Results

NEW HAVEN, Conn., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics companyΒ  Precipio, Inc. (NASDAQ: PRPO) announces third-quarter financial results for the quarter ending September 30, 2026.

GlobeNewsWireΒ·25d ago

Precipio Announces Q3-2026 Shareholder Update Call

NEW HAVEN, Conn., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Β  (NASDAQ: PRPO) , will be hosting its Q3-2026 shareholder update call on November 10th, 2026, at 5:00 PM ET.

Defense WorldΒ·Oct 23

Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Here’s Why

Precipio, Inc. (NASDAQ: PRPO - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $25.20 and traded as low as $20.

Seeking AlphaΒ·Oct 12

Precipio: Management Dreams Big, Institutions Have A Toe In

Precipio is an established laboratory services provider in cancer diagnostics and has launched a razor and razor blade model for facilities to test their own samples on site. 16.6% of the stock is held by officers and di